References
- Hopkins PN. A survey of 246 suggested coronary risk factors. Atherosclerosis 1981; 40: 1–52
- Levy D, Garrison RJ, Savage DD, Kannel WB. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566
- Mac Mahon SW, Wilcken DE. The effect of weight reduction on left ventricular mass: a randomised controlled trial in young, overweight hypertensive patients. N Engl J Med 1986; 314: 334–9
- Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95–110
- The Fifth Report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154–83
- Anderson KM, Wilson P WF, Odell PM, Kannel W B. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356–62
- Dawber TR, Meadors GF, Moore F EJ. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951; 41: 279–286
- Kannel WB, Feinleib M, Namara PM, Garrison RJ, Castelli W P. An investigation of coronary heart disease in families: The Framingham Offspring Study. Am J Epidemiol 1979; 110: 281–290
- Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram; prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med 1969; 71: 89–105
- Peto R, Collins R, Mahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologic context. Lancet 1990; 335: 827–38
- The Systolic Hypertension in the Elderly Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–3264
- Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281–1285
- Kannel WB, Dawber TR, McGee D L. Perspectives on systolic hypertension. The Framingham Study. Circulation 1980; 61: 1179–83
- Stamler J, Neaton JD, Wentworth D N. Blood pressure (systolic and diastolic) and risk of fatal coroanry disease. Hypertension 1993; 13(suppl 1)2–12
- Wolf PA, Agostino RB, Belanger AJ, Kannel W B. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 3: 312–318